BioInformants two newest market researchs report offers mission-critical insight into the complex but lucrative world of embryonic stem cell product development and patent licensing. To promote these excellent products, Global Information Inc is offering our first 10 customers an Amazon Kindle Fire tablet with their purchase, as well as a copy of BioInformants 2012 Marketing Database of Stem Cell Researchers, a combined $1500 value, absolutely free.
Companies interested in developing human embryonic stem cell products have to navigate a risky product environment. Due to the long-standing and controversial patents held by the University of Wisconsins Alumni Research Foundation (WARF), companies have been largely hindered by the intellectual property (IP) environment restricting the development of embryonic stem cell products. However, going where competitors fear to tread means tremendous financial rewards are available for the companies that move boldly forward.
Human embryonic stem cells offer tremendous therapeutic potential, as they can develop into over 200 different cell types. However, up until now, WARF has had the power to largely control what companies can develop embryonic stem cell products and on what terms. With the release of BioInformants report Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products, published June 2012, research supply companies can now receive clear guidance for navigating the hazards of embryonic stem cell product development.
The report reveals critical alternatives to traditional WARF licensing, such as moving research overseas, establishing collaborations with companies that are existing WARF licensees, structuring creative negotiating alternatives, developing products for other species and other breakthrough strategies.
BioInformants report also offers historical and future growth projections for the embryonic stem cell product market, competitive analysis of existing providers, and detailed assessment of creative strategies for developing high-demand products. This insight is possible, because BioInformant has been the global leader in stem cell industry data since 2006 and is the only producer of market intelligence data specific for the stem cell sector.
Free samples from the full document are available at: https://www.giiresearch.com/report/biof242923-opportunities-human-embryonic-stem-cell-product.html
Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights, and BioInformant also offers a sophisticated market intelligence report for the stem cell research supply market.
Whether you already supply stem cell research products or you wish to expand your product line, youll know just how essential and lucrative this market is. We know you want to make effective product development decisions, to sell more effectively to scientists, to generate improved revenues and take market share from your competition.
Stem Cell Research Products - Opportunities, Tools, and Technologies - published in May 2012 - shows you how to do just that. Helping you understand the prevailing market conditions and giving you guidance to strategically position and develop stem cell product lines.
So when you choose our industry-leading market report, youll be gaining a competitive advantage in three core areas.
To see the details of those core areas, and to view free samples from the full document, please visit the report page at: https://www.giiresearch.com/report/biof238169-stem-cell-research-products-opportunities-tools.html
Global Information (GII) (https://www.giiresearch.com) is an information service company partnering with over 400 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.